Lactoferrin, Anti-Lactoferrin Antibodies and Inflammatory Disease

  • Thomas Skogh
  • Elisabeth Peen
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 336)


The nucleophilic properties of human lactoferrrin (Lf) were demonstrated by immunofluorescence microscopy using cryostat rat tissue sections, and the nuclear/perinuclear distribution of Lf in ethanol-fixed human neutrophils was visualized with rabbit anti-human Lf, producing a P-ANCA/GS-ANA staining pattern. Prevention of complement activation by Lf was confirmed in a haemolytic assay. Antibodies (IgG) against human Lf were studied by ELISA in sera from patients with Crohn’s disease, ulcerative colitis, primary sclerosing cholangitis, rheumatoid arthritis, systemic lupus erythematous and primary Sjögren’s syndrome. Anti-Lf antibodies were found in high frequency in ulcerative colitis and primary sclerosing cholangitis, but only occasionally in the other conditions.


Systemic Lupus Erythematosus Inflammatory Bowel Disease Ulcerative Colitis Primary Sclerosing Cholangitis Sjogrens Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Birgens H. The interaction of lactoferrin with human monocytes. (Review) Dan.Med. Bull. 1991; 38: 244252Google Scholar
  2. Briggs RC, Glass II WF, Montiel MM, Hnilica LS (1981): Lactoferrin: Nuclear localizaation in the human neutrophilic granulocyte? J.Histochem.Cytochem. 29: 1128–36PubMedCrossRefGoogle Scholar
  3. Coremans IEM, Hagen EC, van der Woude FJ et al (1992): Anti-lactoferrin antibodies in patients with rheumatoid arthritis with vasculitis. Clin.Rheumatol. 11: 4Google Scholar
  4. Davidson LA, Lönnerdal B. Specific binding of lactoferrin to brush border menbrane: ontogeny and effect of glycan chain. Am.J.Physiol. 1988; 254: G580–85PubMedGoogle Scholar
  5. Esaguy N, Aguas AP, van Embden JDA, Silva MT (1991): Mycobacteria and human autoimmune disease: direct evidence for cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli. Inf.Immun. 59: 1117–25Google Scholar
  6. Goldschmeding R. Target antigens of antineutrophil cytoplasmic antibodies. Thesis (MD), Amsterdam 1992Google Scholar
  7. Kijlstra A. The role of lactoferrin in the nonspecific immune response on the occular surface. Reg.Immunol. 1990–91; 3: 193–97Google Scholar
  8. Peen E, Abner S, Bodemar G, Ryden B-0, Sjölin C, Tejle K, Skogh T (1993): Anti-lactoferrin antibodies and other types of “ANCA” in Crohn’s disease, ulcerative colitis, and primary sclerosing cholangitis. Gut 34: 56–62PubMedCrossRefGoogle Scholar
  9. Skogh T, Dahlgren C, Holmgren K, Peen E, Stendahl 0 (1991): Anti-granulocyte anti-bodies (C-ANCA, P-ANCA, GS-ANA) studied by confocal scanning laser fluorescence microscopy, ELISA, and chemiluminescence techniques. Scand J Immunol. 34: 137–45Google Scholar
  10. Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, Pittilo RM, Rowles PM, Hudson M, Lewis AAM, Pounder RE (1991): Granulomatous vasculitis in Crohn’s disease. Gastroenterology 100: 1279–87PubMedGoogle Scholar
  11. Wiik A (1980): Granulocyte-specific antinuclear antibodies. Allergy 35: 263–89PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Thomas Skogh
    • 1
    • 2
  • Elisabeth Peen
    • 1
    • 3
  1. 1.Clin.Immunol.Lab.Dpt.Med.MicrobiologySweden
  2. 2.Rheumatology Clinic, Dpt.Internal Medicine Faculty of Health SciencesUniversity of LinköpingLinköpingSweden
  3. 3.Dpt. Internal MedicineHaukeland HospitalBergenNorway

Personalised recommendations